Clinical trial
A Cancer Research UK Phase I/II Trial of ALETA-001 in Participants Who Have Received an Anti-CD19 CAR T-Cell Therapy for the Treatment of B-cell Malignancies
NCT06045910 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cancer Research UK Phase I/II Trial of ALETA-001 in Participants Who Have Received an Anti-CD19 CAR T-Cell Therapy for the Treatment of B-cell Malignancies
- Lead sponsor
- Cancer Research UK
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- February 7, 2024
- Completion date
- December 21, 2029
- Enrollment
- 84 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
large b-cell lymphoma, lymphoma, b-cell, lymphoma, follicular, lymphoma, large b-cell, diffuse, lymphoma, mantle-cell, lymphoma, non-hodgkin